Reply to: Non-invasive tests and advanced chronic liver disease in NAFLD: two steps forward and one step back?

Gut. 2022 Jul;71(7):1453-1454. doi: 10.1136/gutjnl-2021-326313. Epub 2021 Oct 27.

Authors

Michael Pavlides^{1

2

3}, Ferenc E Mózes⁴, Stephen A Harrison⁴

Affiliations

¹ Cardiovascular Medicine, Radcliffe Department of Medicine, Oxford University, Oxford, UK michael.pavlides@cardiov.ox.ac.uk.
² Translational Gastroenterology Unit, University of Oxford, Oxford, UK.
³ NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust and the University of Oxford, Oxford, UK.
⁴ Cardiovascular Medicine, Radcliffe Department of Medicine, Oxford University, Oxford, UK.

No abstract available

Keywords: fatty liver; hepatocellular carcinoma; liver cirrhosis.

Publication types

Letter
Comment

MeSH terms

Carcinoma, Hepatocellular* / pathology
Humans
Liver / pathology
Liver Cirrhosis / pathology
Liver Neoplasms* / pathology
Non-alcoholic Fatty Liver Disease* / complications
Non-alcoholic Fatty Liver Disease* / diagnosis
Non-alcoholic Fatty Liver Disease* / pathology